Regeneron Pharmaceuticals, INC.
Biopharmaceutical development and manufacturing
Based in NY
🤖
AI Overview
With $10K in lobbying spend across 20 quarterly filings, Regeneron Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2025.
$10K
Total Spend
5
Years Active
1
Firms Hired
6
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $10K |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Copyright/Patent, Medicare/Medicaid
- •Engagement on trade policy developments
- •Engagement on international trade policy.
Related Analysis
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.